R&D News | pharmaphorum

News

Moderna banks on OpenAI to accelerate mRNA research

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI)

News

Endeavor raises $132.5m for fibrosis, cancer drugs

Endeavor BioMedicines has completed a third round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi

News

Roche says it has shed 20% of NMEs from its pipeline

Roche chief executive Thomas Schinecker said today that one in five of the pharma division’s pipel

News

Xaira Therapeutics co-founder Dr David Baker

Enter Xaira, with $1bn for its AI in drug discovery platform

Any new company wanting to make waves in applying artificial intelligence to drug discovery will need deep pockets and a top-tier science and management team – and startup

News

Sanofi’s oral BTK programme gets back on track

Sanofi has chalked up another win in a clinical trial of its oral BTK inhibitor rilzabrutinib, setting up regulatory filings in its first indication – rare disorder immune

News

Shakeup at BenevolentAI continues with job, programme cuts

BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third

Moderna banks on OpenAI to accelerate mRNA research

Endeavor raises $132.5m for fibrosis, cancer drugs

Roche says it has shed 20% of NMEs from its pipeline

Enter Xaira, with $1bn for its AI in drug discovery platform

Sanofi’s oral BTK programme gets back on track

Shakeup at BenevolentAI continues with job, programme cuts

Bankruptcy threat looms as Quince runs out of options

How to meet your physicians where they are online

News

Editor's Picks